News

Multiple myeloma, a cancer of the bone marrow, remains difficult to treat despite modern CAR T cell therapies. In “Molecular Therapy,” a team led by Armin Rehm presents an improved immunotherapy that recognizes two distinct features of malignant cells to destroy the cancer more effectively.

The Einstein Center for Early Disease Interception has been funded with six million euros. In an interview, Nikolaus Rajewsky and Leif Erik Sander, both spokespeople of the center, explain why new technologies and cross-institutional collaboration will make disease prevention in the future possible.

During the Predictive Systems Medicine Partnering Event at the Max Delbrück Center, researchers and industry representatives shared insights and explored commercialization opportunities – advancing our mission to turn discovery into real-world health impact.

Researchers at the Max Delbrück Center have found that a cellular housekeeping mechanism called autophagy plays a major role in ensuring that T stem cells undergo normal cell division. The findings, published in “Nature Cell Biology,” could help boost vaccine response in older adults.

The Max Delbrück Center and Berlin Institute of Health at Charité have joined a national network of six Genome Data Centers and the German Human Genome-Phenome Archive, adding Berlin as an operational data hub for genomic medicine and omics-based research.

A team led by Mina Gouti has developed a stem cell-based model that enables researchers to test new drugs to treat neuromuscular diseases and to refine existing therapies. The project, called NMJCare, was named one of the top ten ideas in the national Science4Life start-up competition.

The Max Delbrück Center has recently completed construction of a new Demonstrator Lab as a testbed to reduce the environmental impact of biomedical research. The insights gained will be applied to all new building renovations across the center.

Karen Christman, a Stiftung Charité Visiting Fellow at the Max Delbrück Center, is among the first researchers to have won a Humboldt Research Award under Germany’s Global Minds Initiative. The award will enable her to expand her research in Germany on bioengineering.

Jana Kroll, Christian Rosenmund and their teams have captured the fleeting moment a nerve cell releases its neurotransmitters into the synaptic cleft. The work was published in “Nature Communications.”

Alessia Negroni is a PhD student in Norbert Hübner’s lab, where she investigates pediatric hearts at single-cell resolution. Beyond the lab, she’s a passionate reader, and recommends the latest novel by a contemporary Mexican author — a moving story about friendship and the ambivalences of motherhood.